MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. - Limagne E; Nuttin L; Thibaudin M; Jacquin E; Aucagne R; Bon M; Revy S; Barnestein R; Ballot E; Truntzer C; Derangère V; Fumet JD; et al. (Cancer cell, 2022)